Blueprint Medicines
BPMC
NZ$217.22
Share price
0.00%
Change (1 day)
16.19%
Change (1 year)
Categories
Blueprint Medicines (BPMC) - Net assets
Net assets on the balance sheet as of March 2025 : NZ$0.57 Billion
According to Blueprint Medicines
's latest financial reports the company has NZ$0.57 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Blueprint Medicines - Net assets on balance sheet (from 2014 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $NZ$0.52 B | 156.42% |
| 2023-12-31 | $NZ$0.20 B | -74.52% |
| 2022-12-31 | $NZ$0.81 B | -42.96% |
| 2021-12-31 | $NZ$1.42 B | -30.25% |
| 2020-12-31 | $NZ$2.03 B | 195.5% |
| 2019-12-31 | $NZ$0.68 B | 10.38% |
| 2018-12-31 | $NZ$0.62 B | -28.9% |
| 2017-12-31 | $NZ$0.87 B | 185.62% |
| 2016-12-31 | $NZ$0.30 B | 46.22% |
| 2015-12-31 | $NZ$0.21 B | 365.23% |
| 2014-12-31 | $NZ$45.21 M | -2583.85% |
| 2013-12-31 | $-NZ$1.83 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Isoray
ISR | NZ$92.29 M | -83.92% | 🇺🇸 USA |
 OPKO Health
OPK | NZ$2.20 B | 283.38% | 🇺🇸 USA |
 Pacific Biosciences
PACB | NZ$0.15 B | -73.22% | 🇺🇸 USA |